Modulating the Gut‐Microbiota‐Brain Axis in Alzheimer's Disease: Therapeutic Potential of Nutritional and Metabolic Factors
CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)
DOI: 10.1002/cns.71117 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 30.08.2026. Verfasst von Binyue Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome, Brain, Brain-Gut Axis. Die Arbeit nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia among the elderly, characterized by a gradual decline in memory and cognitive function. The growing body of evidence highlighting the interaction between the gut microbiota and the central nervous system has positioned the gut microbiota as a key area of research in AD pathogenesis.
Methods
This review critically evaluates the preclinical evidence and clinical trial outcomes, complemented by mechanistic studies and Mendelian randomization analyses, to assess the therapeutic potential of nutritional interventions targeting the gut‐microbiota‐brain axis in AD.
Results
Dietary components and patterns regulate the composition and function of the gut microbiota, which in turn influence brain function through the gut‐microbiota‐brain axis via chemical/metabolic, immune‐mediated, and neural pathways. Specific nutrients, microbial metabolites, and dietary patterns have been shown to exert either protective or detrimental effects on AD pathology and cognitive function. Emerging strategies, including precision nutrition, fecal microbiota transplantation, and next‐generation microbiome‐based therapies, offer new avenues for AD prevention and treatment.
Conclusions
Nutritional interventions targeting the gut‐microbiota‐brain axis represent a promising approach for the comprehensive prevention and management of AD. Further mechanistic and clinical studies are warranted to translate these findings into effective therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatric Medicine, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
ORCID-Profile: Binyue Xu, Jiesheng Wang
Zitieren
APA
Xu, B., Li, X., Dong, S., Zhang, Z., Jin, D., Li, G., & Wang, J. (2026). Modulating the Gut‐Microbiota‐Brain Axis in Alzheimer's Disease: Therapeutic Potential of Nutritional and Metabolic Factors. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.71117
Vancouver
Xu B, Li X, Dong S, Zhang Z, Jin D, Li G, et al. Modulating the Gut‐Microbiota‐Brain Axis in Alzheimer's Disease: Therapeutic Potential of Nutritional and Metabolic Factors. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.71117
BibTeX
@article{Xu2026,
author = {Xu, Binyue and Li, Xuhuan and Dong, Shangling and Zhang, Zheyuan and Jin, Dong and Li, Guoping and Wang, Jiesheng},
title = {Modulating the Gut‐Microbiota‐Brain Axis in Alzheimer's Disease: Therapeutic Potential of Nutritional and Metabolic Factors},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {9},
doi = {10.1002/cns.71117}
}
EUVIMED